Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy QuestionsBenzinga • 07/13/21
Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney DiseaseGlobeNewsWire • 06/25/21
FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune DiseaseGlobeNewsWire • 06/17/21
Pamrevlumab Included in Pancreatic Cancer Action Network's Adaptive Clinical Trial PlatformGlobeNewsWire • 06/16/21
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in FibroGen, Inc. of Class Action Lawsuit and Upcoming Deadline - FGENNewsfile Corp • 06/12/21
DEADLINE TODAY: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the FirmNewsfile Corp • 06/11/21
Final Day to Actively Participate: FibroGen, Inc. (FGEN) Class Action - Bronstein, Gewirtz & Grossman, LLCNewsfile Corp • 06/11/21
FGEN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 11, 2021 in the Class Action Filed on Behalf of FibroGen, Inc. Limited ShareholdersNewsfile Corp • 06/10/21
FINAL DEADLINE TOMORROW: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the FirmPRNewsWire • 06/10/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of FibroGen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 11, 2021 - FGENNewsfile Corp • 06/10/21
DEADLINE TOMORROW: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the FirmNewsfile Corp • 06/10/21
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for FibroGen, Inc. Investors - FGENNewsfile Corp • 06/10/21
FGEN LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of FibroGen, Inc. ShareholdersNewsfile Corp • 06/09/21
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of FibroGen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 11, 2021 - (FGEN)Newsfile Corp • 06/09/21
FGEN FINAL DEADLINE FRIDAY: ROSEN, A LEADING LAW FIRM, Encourages FibroGen, Inc. Investors with Losses to Secure Counsel Before Important June 11 Deadline in Securities Class Action - FGENPRNewsWire • 06/09/21
FGEN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving FibroGen, Inc.Newsfile Corp • 06/09/21
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN)Business Wire • 06/09/21
FRIDAY DEADLINE NOTICE: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the FirmNewsfile Corp • 06/09/21
FRIDAY DEADLINE REMINDER: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the FirmNewsfile Corp • 06/08/21
JUNE 11 2021 FGEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc.Newsfile Corp • 06/08/21
